1. Home
  2. BDSX vs PSTV Comparison

BDSX vs PSTV Comparison

Compare BDSX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$7.85

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Logo PLUS THERAPEUTICS Inc.

PSTV

PLUS THERAPEUTICS Inc.

HOLD

Current Price

$0.67

Market Cap

61.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDSX
PSTV
Founded
2005
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.0M
61.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDSX
PSTV
Price
$7.85
$0.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$32.50
$7.25
AVG Volume (30 Days)
62.6K
6.1M
Earning Date
11-03-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$80,173,000.00
$5,258,000.00
Revenue This Year
$20.75
$28.21
Revenue Next Year
$25.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.29
N/A
52 Week Low
$3.44
$0.16
52 Week High
$32.20
$2.31

Technical Indicators

Market Signals
Indicator
BDSX
PSTV
Relative Strength Index (RSI) 52.12 58.96
Support Level $7.77 $0.61
Resistance Level $8.38 $0.70
Average True Range (ATR) 0.57 0.05
MACD -0.01 0.01
Stochastic Oscillator 60.38 62.10

Price Performance

Historical Comparison
BDSX
PSTV

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

Share on Social Networks: